T-group (topology)
325.1.1 CO dehydrogenase molybdoprotein N-domain-like
Ligands and drugs
1,207
Member domains
300
with ligand contacts (≤ 4 Å)
24.9% of members
246
with DrugDomain annotations
20.4% of members
188
with a DrugBank compound
15.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 325.1.1 belongs to X-group 325 alpha/beta-Hammerhead/Barrel-sandwich hybrid, which binds 8.9 ligand superclasses per 20 proteins, broader than 75% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB16833 | ADP | Adenosine disphosphate | 32 |
| DB00171 | ATP | ATP | 14 |
| DB01992 | COA | Coenzyme A | 10 |
| DB00121 | — | Biotin | 7 |
| DB02859 | S1A | Soraphen A | 6 |
| DB07497 | BTI | 5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal | 5 |
| DB02137 | PCD | Molybdenum cofactor | 4 |
| DB02236 | GAR | Glycinamide Ribonucleotide | 4 |
| DB03147 | FAD | Flavin adenine dinucleotide | 4 |
| DB01685 | FYX | Topiroxostat | 3 |
| DB03841 | YSH | Niraxostat | 3 |
| DB03909 | ACP | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate | 3 |
| DB04854 | TEI | Febuxostat | 3 |
| DB00627 | NIO | Niacin | 2 |
| DB02930 | AGS | Adenosine 5'-[gamma-thio]triphosphate | 2 |
| DB03148 | A12 | Adenosine 5'-methylenediphosphate | 2 |
| DB03300 | MCN | Pterin Cytosine Dinucleotide | 2 |
| DB03516 | — | Eniluracil | 2 |
| DB04216 | QUE | Quercetin | 2 |
| DB08075 | L22 | 4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ADP | ADENOSINE-5'-DIPHOSPHATE | 50 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 42 |
| ACO | ACETYL COENZYME *A | 22 |
| BTN | BIOTIN | 22 |
| MGmetal | MAGNESIUM ION | 20 |
| COA | COENZYME A | 10 |
| CL | CHLORIDE ION | 9 |
| AIR | 5-AMINOIMIDAZOLE RIBONUCLEOTIDE | 6 |
| S1A | SORAPHEN A | 6 |
| ANP | PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER | 4 |
| GAR | GLYCINAMIDE RIBONUCLEOTIDE | 4 |
| NAmetal | SODIUM ION | 4 |
| RAL | RALOXIFENE | 4 |
| ACP | PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER | 3 |
| 6U3 | 2-[1-[(2~{R})-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-bis(oxidanylidene)thieno[2,3-d]pyrimidin-3-yl]-2-methyl-propanamide | 2 |
| AGS | PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER | 2 |
| FYO | 4-[5-(2,6-dioxo-1,2,3,6-tetrahydropyridin-4-yl)-1H-1,2,4-triazol-3-yl]-6-oxo-1,6-dihydropyridine-2-carbonitrile | 2 |
| FYX | 4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE | 2 |
| IOD | IODIDE ION | 2 |
| L23 | 4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine | 2 |